1. Home
  2. KUKE vs DBVT Comparison

KUKE vs DBVT Comparison

Compare KUKE & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KUKE
  • DBVT
  • Stock Information
  • Founded
  • KUKE 2002
  • DBVT 2002
  • Country
  • KUKE China
  • DBVT France
  • Employees
  • KUKE N/A
  • DBVT N/A
  • Industry
  • KUKE Other Consumer Services
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KUKE Real Estate
  • DBVT Health Care
  • Exchange
  • KUKE Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • KUKE 91.9M
  • DBVT 102.0M
  • IPO Year
  • KUKE 2021
  • DBVT N/A
  • Fundamental
  • Price
  • KUKE $2.89
  • DBVT $6.46
  • Analyst Decision
  • KUKE
  • DBVT Strong Buy
  • Analyst Count
  • KUKE 0
  • DBVT 2
  • Target Price
  • KUKE N/A
  • DBVT $22.50
  • AVG Volume (30 Days)
  • KUKE 227.0K
  • DBVT 1.1M
  • Earning Date
  • KUKE 04-15-2025
  • DBVT 05-06-2025
  • Dividend Yield
  • KUKE N/A
  • DBVT N/A
  • EPS Growth
  • KUKE N/A
  • DBVT N/A
  • EPS
  • KUKE N/A
  • DBVT N/A
  • Revenue
  • KUKE $14,784,158.00
  • DBVT $4,200,000.00
  • Revenue This Year
  • KUKE N/A
  • DBVT $1,679.52
  • Revenue Next Year
  • KUKE N/A
  • DBVT $535.67
  • P/E Ratio
  • KUKE N/A
  • DBVT N/A
  • Revenue Growth
  • KUKE 10.48
  • DBVT N/A
  • 52 Week Low
  • KUKE $0.15
  • DBVT $0.44
  • 52 Week High
  • KUKE $4.07
  • DBVT $7.28
  • Technical
  • Relative Strength Index (RSI)
  • KUKE 68.05
  • DBVT 65.77
  • Support Level
  • KUKE $2.61
  • DBVT $3.91
  • Resistance Level
  • KUKE $3.27
  • DBVT $7.28
  • Average True Range (ATR)
  • KUKE 0.53
  • DBVT 0.60
  • MACD
  • KUKE 0.06
  • DBVT 0.20
  • Stochastic Oscillator
  • KUKE 74.73
  • DBVT 75.67

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: